clenbuterol has been researched along with Glial Cell Tumors in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCauslin, CS | 1 |
| Heath, V | 1 |
| Colangelo, AM | 1 |
| Malik, R | 1 |
| Lee, S | 1 |
| Mallei, A | 1 |
| Mocchetti, I | 1 |
| Johnson, PF | 1 |
1 other study available for clenbuterol and Glial Cell Tumors
| Article | Year |
|---|---|
CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system.
Topics: Adrenergic beta-Agonists; Animals; Brain; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Bindin | 2006 |